Although deep vein thrombosis (DVT) recurrence is a common late complication of the
disease, there are few predictive markers to risk-stratify patients long-term after the …

Background The association between venous and arterial thrombotic disorders is still
unclear. We assessed the association between residual vein thrombosis (RVT) and …

Venous thromboembolism (VTE), including pulmonary embolism and deep venous
thrombosis, is the third most common cause of cardiovascular death. The management of …

Venous thromboembolism is commonly encountered both in the community and the in-
patient setting. Despite major advances in diagnosis and treatment, there remain challenges …

How long is long enough? Extended anticoagulation for the treatment of cancer-associated
deep vein thrombosis. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

Introduction: Idiopathic or unprovoked venous thromboembolism is an event occurring in the
absence of any apparent provoking or triggering environmental risk factors, such as surgery …

El diagnóstico urgente de una tromboembolia pulmonar (TEP) aguda se beneficia del uso
de pautas de decisión clínica basadas en la evidencia que mejoran el pronóstico de los …

Patients with pulmonary embolism are a heterogeneous population and, after the acute
phase and the first 3-6 months, the main issue is whether to continue, and hence how long …

Venous thromboembolism (VTE) is associated with a risk of recurrence that depends on
factors specific to index event and patient. A first unprovoked VTE increases the risk of a …

Venous thromboembolism (VTE) is a frequent complication in cancer patients and
represents an important cause of morbidity and mortality. The treatment of VTE …